LPL Financial’s CureVac CVAC Stock Holding History

LPL Financial’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,966	Closed	-$308K	–	4225
2021 Q4	$308K	Buy	+8,966	New	+$361K	﹤0.01%	3662
2021 Q3	–	Sell	-3,757	Closed	-$276K	–	4342
2021 Q2	$276K	Buy	3,757 +600	+19%	+$60K	﹤0.01%	3651
2021 Q1	$289K	Buy	+3,157	New	+$306K	﹤0.01%	3488

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial's CVAC Position: Q1 2022 in Review

LPL Financial sold out of CureVac (CVAC) in Q1 2022, closing a stake of 8,966 shares — an estimated $308K sold.

LPL Financial first reported a position in CVAC in Q1 2021 and held it in 3 quarters. The position peaked at $308K in Q4 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

LPL Financial reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
LPL Financial sold 8,966 CureVac shares in Q1 2022, an estimated $308K.
LPL Financial first reported a position in CureVac in Q1 2021 and held it in 3 quarters.
LPL Financial's CureVac position peaked at $308K in Q4 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on LPL Financial's 13F filing for Q1 2022, filed 16 May 2022.